| $385M | ||
| $350M | ||
| $215M | ||
| $100M | ||
| $83M | ||
| $63M |
Buys | $0 | 0 | 0 |
Sells | $2,019,942 | 62 | 100 |
| Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 0 | $0 | 62 | $2.02M | $-2.02M |
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of NSCLC; nivolumab and ipilimumab, a CTLA-4 antibody for the treatment of SCLC; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers. In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York.
Over the last 12 months, insiders at BeyondSpring Inc. have bought $0 and sold $2.02M worth of BeyondSpring Inc. stock.
On average, over the past 5 years, insiders at BeyondSpring Inc. have bought $0 and sold $2.02M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
| 2025-10-17 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 45,513 0.1324% | $1.76 | $80,103 | -3.39% | |
| 2025-10-16 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 85,798 0.2439% | $1.72 | $147,573 | -4.47% | |
| 2025-10-15 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 17,960 0.049% | $1.65 | $29,634 | +3.94% | |
| 2025-10-14 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 28,495 0.0777% | $1.65 | $47,017 | +4.27% | |
| 2025-10-13 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 107,361 0.3017% | $1.70 | $182,514 | 0.00% | |
| 2025-10-10 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 2,390 0.007% | $1.77 | $4,230 | -1.72% | |
| 2025-10-09 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 3,979 0.0119% | $1.81 | $7,202 | -5.52% | |
| 2025-10-08 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 7,507 0.022% | $1.77 | $13,287 | -4.47% | |
| 2025-10-07 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 2,100 0.0062% | $1.79 | $3,759 | -4.72% | |
| 2025-10-06 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 17,500 0.0515% | $1.78 | $31,150 | -3.37% | |
| 2025-10-03 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 600 0.0017% | $1.76 | $1,056 | -1.71% | |
| 2025-10-02 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 600 0.0017% | $1.73 | $1,038 | -0.58% | |
| 2025-10-01 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 2,601 0.0077% | $1.80 | $4,682 | -3.63% | |
| 2025-09-30 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 4,464 0.0134% | $1.81 | $8,080 | -4.42% | |
| 2025-09-29 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 500 0.0014% | $1.75 | $875 | -0.57% | |
| 2025-09-26 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 600 0.0017% | $1.68 | $1,008 | -1.70% | |
| 2025-09-25 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 700 0.0019% | $1.66 | $1,162 | +2.98% | |
| 2025-09-24 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 2,256 0.0063% | $1.68 | $3,790 | +2.37% | |
| 2025-09-23 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 4,106 0.0117% | $1.72 | $7,062 | +4.22% | |
| 2025-09-22 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 5,410 0.0164% | $1.83 | $9,900 | -3.35% |
| Increased Positions | 11 | +55% | 558,325 | +9.43% |
| Decreased Positions | 7 | -35% | 492,626 | -8.32% |
| New Positions | 6 | New | 261,105 | New |
| Sold Out Positions | <1 | Sold Out | 1,080 | Sold Out |
| Total Postitions | 24 | +20% | 6M | +1.11% |